Platelet Rich Plasma Following Hysteroscopic Adhesolysis

Platelet Rich Plasma Following Hysteroscopic Adhesolysis: A Randomized Clinical Trial

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03881215

Enrollment

160

Registered

2019-03-19

Start date

2016-01-01

Completion date

2020-01-10

Last updated

2020-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intra-uterine Adhesions

Brief summary

Platelet Rich Plasma Following Hysteroscopic Adhesolysis: A Randomized Clinical Trial

Interventions

PROCEDUREPlatelet Rich Plasma

Platelet Rich Plasma

PROCEDUREintra-uterine balloon

intra-uterine balloon

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

PREVENTION

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 40 Years

Healthy volunteers

Inclusion criteria

* Age: 18-40 years * Grade III intra-uterine adhesions

Exclusion criteria

* Age \< 18 or \> 40 years. * Hb \< 11 g/dL, platelets \< 150.000/mm3. * Patient taking anticoagulant. * Patient taking NSAID in the 10 days before procedure. * Any significant comorbidity or psychiatric disorder that would compromise patient's consent. * Active cervical or uterine infection. * Undiagnosed genital bleeding. * pregnancy.

Design outcomes

Primary

Measure	Time frame	Description
Incidence of adhesion recurrence	3 months	recurrence of severe intra-uterine adhesions

Secondary

Measure	Time frame	Description
Days of menses	3 months	Number of days of menstrual cycle following operation
Amount of menses	3 months	Number of sanitary pads changed during each menstrual cycle

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026